Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase EARLY_PHASE1 2Phase 4 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Venous Thrombosis 1Respiration Disorders 1Pulmonary Embolism 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Lung Diseases 1Brain Neoplasms 1

Interventions

Saline Solution 5Sugammadex 2Sodium Chloride 2Sevoflurane 2Propofol 2Magnetic Resonance Spectroscopy 2Levetiracetam 2Fluorescein 2Dexmedetomidine 2Anesthesia, Inhalation 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1perampanel 1pegvisomant 1lorlatinib 1gadoterate meglumine 1gadobenic acid 1dexketoprofen trometamol 1clevidipine 1Trastuzumab 1Tramadol 1Temozolomide 1Positron-Emission Tomography 1Phenylephrine 1Patient-Specific Modeling 1PF-05280014 1PAVE protocol 2 1Ontruzant 1Ogivri 1Octreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Brain Neoplasms × Fluorodeoxyglucose F18 × Clear all
NCT05054998 2024-05-01

Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases

M.D. Anderson Cancer Center

Phase 4 Completed
12 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡